JNJDeep.Dive

Healthcare · Drug Manufacturers - General · 2026-06-01

$221.59

-1.66%

6mo, weekly closes · $151.25 → $221.59 (+46.50%)

[JNJ] Deep Dive

Date: 2026-06-01 | Price: $221.59 (-1.66%)

Template fallback — no LLM narrative was generated for this run.

Market Snapshot

Metric	Value
Market Cap	$533.40B
Sector	Healthcare / Drug Manufacturers - General
Beta	0.26
52W Range	$197.72 - $250.27
Analyst Target	$252.87
TradingView	N/A

Technicals

EMA Stack: TANGLED
Trend: ↓ Bearish (Golden Cross)
EMAs: 8=$227.24 · 21=$227.75 · 34=$228.65 · 55=$229.32 · 89=$228.02
SMAs: 20=$226.29 · 50=$230.99 · 100=$231.24 · 200=$209.77
RSI(14): 51.98 · ADX(14): 8.62
Pivots: R2=$234.05 · R1=$229.69 · PP=$227.14 · S1=$222.78 · S2=$220.23
ATR(14): 4.30 · Rel Vol: 0.26x

Valuation

Status: OVERVALUED (Gap: -36.93%)
Fair-value target: $139.75
Method: BLENDED (Graham+Lynch+Analyst)

Fundamentals

Revenue Growth: 9.90%
Profit Margin: 21.83%
P/E: 25.68 · Forward P/E: 17.42

_Deterministic template. Wire GEMINI_API_KEY to get the full narrative._

▮ Technical GearboxREL VOL 0.26x

Volatility

30.78%

HV30

19.88%

IV RANK

3.07%

IV PCTL

26.92%

Trend

▼

SHORT

↓ Bearish

▼

MID

↓ Bearish

▲

LONG

↑ Bullish

EMA STACKTANGLED TV RECN/A CROSSOVERGolden Cross

Moving Averages

SMA

SMA 20

226.29

-2.08%

SMA 50

230.99

-4.07%

SMA 100

231.24

-4.17%

SMA 200

209.77

+5.63%

EMA

EMA 8

227.24

-2.49%

EMA 21

227.75

-2.70%

EMA 34

228.65

-3.09%

EMA 55

229.32

-3.37%

EMA 89

228.02

-2.82%

Oscillators

RSI(14)

51.98

STOCH %K/%D

8.7 / 42.6

MACD HIST

0.0380

ADX

8.62

52-Week Range

LOW $197.72 NOW $221.59 (45.4%) HIGH $250.27

Fibonacci

FIB 0.236$237.87

FIB 0.382$230.19

FIB 0.500$223.99

FIB 0.618$217.79

Keltner & Pivots

KELT UPPER$234.18

KELT MID$226.29

KELT LOWER$218.40

ATR(14)4.30

R2 $234.05 · R1 $229.69 · PP $227.14 · S1 $222.78 · S2 $220.23

▮ Composite Scores

VALUE

GROWTH

QUALITY

SENTIMENT

▮ Fundamental Dashboard

Profile

COMPANY

Johnson & Johnson

MARKET CAP

$533.40B

EMPLOYEES

138200

EXCHANGE

NYQ

Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. [ https://www.jnj.com ]

Valuation

P/E

25.68

FWD P/E

17.42

P/S

5.54

P/B

6.57

EV/EBITDA

16.76

PEG

2.93

STATUSOVERVALUEDFAIR VAL$139.75GAP-36.93%METHODBLENDED (Graham+Lynch+Analyst)EV/REV5.97P/FCF42.63

Growth

REV GROWTH+9.90%

EARN GROWTH-52.90%

EARN Q GROWTH-52.40%

REV/SHARE$40.02

Profitability

GROSS MARGIN68.04%

OP MARGIN27.41%

NET MARGIN21.83%

ROE26.42%

ROA8.42%

Financial Health

CURRENT RATIO

1.02

D/E

67.73

DEBT

$54.99B

CASH

$22.05B

FCF

$12.51B

OP CF

$22.87B

Dividends

DIV YIELD2.42%

DIV RATE$5.36

PAYOUT60.25%

EX-DIV2026-05-26

Analyst Estimates

RECbuy

# ANALYSTS23

TARGET MED$260.00

LOW $155.00 MED $260.00 HIGH $285.00